Levels and prognostic impact of circulating markers of inflammation, endothelial activation and extracellular matrix remodelling in patients with lung cancer and chronic obstructive pulmonary disease

Table 3 Serum protein levels in lung cancer patients and COPD patients. LC^COPD –lung cancer with COPD. LC^only –lung cancer with and without COPD

ANOVA and MANCOVA analyses comparing circulating protein levels in patients with COPD and patients with lung cancer with and without COPD. One-way MANCOVA was performed on two groups (COPD and Lung cancer with and without COPD), and on three groups (COPD, lung cancer with COPD and lung cancer without COPD). One-way ANOVA was conducted to explore the differences in the levels of proteins between the three groups; COPD (n = 42), lung cancer with COPD (n = 116) and lung cancer without COPD (n = 92). Multiple testing is controlled for by Bonferroni correction. Only significant markers are shown

ISSN: 1471-2407